SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1656I used to work for a bank that for the longest time was a short at any price. Fitom pope-4/24/2008
1655Enbrel was the only bright spot. Imagine how bad these results would have been iDewDiligence_on_SI-4/24/2008
1654Amgen first-quarter profits nearly flat on declining sales The Associated Press JGoren-4/24/2008
1653Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent tJGoren-4/24/2008
1652citi: 4.10.08 Roche's Appeal Should End Up Favoring Amgen ? Conclusion(s) —mopgcw-4/17/2008
1651Romiplostim PDUFA date goes from 4/23 to 7/23 >>Amgen Statement on Romipltuck-4/8/2008
1650citi 4.2.08 : Amgen Inc (AMGN) Data Won't DEFEND Dmab From Safety Concerns mopgcw-4/5/2008
1649Citi 4.3.08: Amgen Inc (AMGN) Amgen v. Roche Teleconference: Young Seems to Be mopgcw-4/5/2008
1648Merrill - Denosumab safety Study had increase in serious infections and malignatom pope-4/3/2008
1647Amgen Drug Helps Bones DOW JONES NEWSWIRES April 4, 2008; Page B16 THOUSAND OADoc Bones-4/3/2008
1646Merrill - a bit fuzzy in the concluding paragraph, at least for someone lookingtom pope-4/1/2008
1645citi 3.26.08: Amgen Fires Back by Threatening to Sue for Damages ? Conclusion —mopgcw-4/1/2008
1644It's going to be a few months before we know which direction Judge Young wiltuck-3/26/2008
1643Roch are hoping that judge Young will grant them a compulsory license but he hasidos-3/24/2008
1642Roche to Increase Royalty To Amgen for Anemia Drug By JEANNE WHALEN March 19, Doc Bones-3/19/2008
1641Merrill finds that short term trading is not easy AMGN no longer a favorable shtom pope-3/14/2008
1640And the last bit of bad news is actually ODAC did limit some settings. ODAC vottuck-3/13/2008
1639And now the bad news. While the panel voted against limiting ESAs only to lung tuck-3/13/2008
1638ODAC votes to allow Amgen to keep the anemia due to cancer indication, which hastuck-3/13/2008
1637Platelet Treatment Wins FDA Panel's Support By JENNIFER CORBETT DOOREN andDoc Bones-3/13/2008
1636Nplate given thumbs up by ODAC: >>Amgen Statement on Successful Outcome otuck-3/12/2008
1635MEMY restructures AMGN PDE10 collaboration: siliconinvestor.comDewDiligence_on_SI-3/12/2008
1634New Anemia-Drug Restrictions Possible J&J, Amgen Brace For FDA Advisory ODoc Bones-3/12/2008
1633Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny [NYT] By ANDoc Bones-3/12/2008
1632Merrill sees a trading opportunity Short term trading opportunity Favorable Ristom pope-3/11/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News